baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

CDAX-GESAMTINDEX (PERF)/ DE0008469602

CDAX

5/3/2024 5:50:00 PM	Chg. +8.61	Open	High	Low	Previous Close
1,555.23XXP	+0.56%	1,546.61	1,564.62	1,546.61	1,546.62
1,555.23XXP	+0.56%	1,546.61	1,564.62	1,546.61	1,546.62

TeleTrader 4/6/2017 VW teams up with Mobvoi for AI-assisted driving

GlobeNewswire 3/29/2017 Hawesko Holding AG: Dividend continuity

GlobeNewswire 1/31/2017 Hawesko Holding AG: Hawesko Holding slightly exceeds expectations

GlobeNewswire 1/12/2017 Hawesko Holding AG: Hawesko Group strengthens positioning in fine wine segment with ultra-premium sp...

GlobeNewswire 12/13/2016 MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or...

GlobeNewswire 12/6/2016 MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 201...

GlobeNewswire 12/6/2016 MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016

GlobeNewswire 11/29/2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...

GlobeNewswire 11/28/2016 MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application Fo...

GlobeNewswire 11/25/2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...

GlobeNewswire 11/22/2016 Correction of a release from 21.11.2016, 18:05 CET - MorphoSys AG: Publication pursuant to §26 sect....

GlobeNewswire 11/21/2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...

GlobeNewswire 11/21/2016 MorphoSys AG: Notification of managers`transactions according to article 19 MAR

GlobeNewswire 11/17/2016 MorphoSys Announces That Its Licensee Janssen Has Submitted Biologics License Application For Guselk...

GlobeNewswire 11/17/2016 MorphoSys AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of...

GlobeNewswire 11/15/2016 MorphoSys Raises EUR 115 million in Private Placement

GlobeNewswire 11/15/2016 Ad hoc: MorphoSys Raises EUR 115 million in Private Placement

GlobeNewswire 11/15/2016 MorphoSys to Raise Capital via a Private Placement of New Shares

GlobeNewswire 11/15/2016 Ad hoc: MorphoSys to Raise Capital via a Private Placement of New Shares

GlobeNewswire 11/15/2016 MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in ...

GlobeNewswire 11/14/2016 Hawesko Holding AG: Raimund Hackenberger will become the new chief financial officer

GlobeNewswire 11/14/2016 MorphoSys to Present at Upcoming Investor Conferences

GlobeNewswire 11/8/2016 Anke Linnartz joins MorphoSys as Head of Corporate Communications and Investor Relations

GlobeNewswire 11/7/2016 MorphoSys AG Reports Results for the First Nine Months of 2016

CDAX-GESAMTINDEX (PERF)/ DE0008469602

If you wish to receive reply to your feedback, please provide your email address.